Literature DB >> 10558953

Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses.

E Cenci1, A Mencacci, G Del Sero, A Bacci, C Montagnoli, C F d'Ostiani, P Mosci, M Bachmann, F Bistoni, M Kopf, L Romani.   

Abstract

Aspergillus fumigatus, an opportunistic fungal pathogen, causes multiple allergic and nonallergic airway diseases. Invasive pulmonary aspergillosis (IPA) is a nonallergic, life-threatening disease of immunocompromised patients. In a murine model of IPA, interleukin (IL)-4-deficient (IL-4-/-) BALB/c mice were used to examine the role of IL-4 in lung pathology and immune responses. IL-4-/- mice were more resistant than wild-type mice to infection caused by multiple intranasal injections of viable A. fumigatus conidia. Resistance was associated with decreased lung inflammatory pathology, impaired T helper (Th)-2 responses (including lung eosinophilia), and an IL-12-dependent Th1 response. In contrast, development of host-detrimental antifungal Th2 cells occurred in IL-12-/- and interferon-gamma-/- mice and in IL-4-/- mice when subjected to IL-12 neutralization. These results demonstrate that IL-4 renders mice susceptible to infection with A. fumigatus by inhibition of protective Th1 responses. IL-4 appears to have a distinct role in the pathogenesis of allergic and nonallergic lung diseases caused by the fungus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558953     DOI: 10.1086/315142

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

Review 1.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 2.  Aspergillus fumigatus: principles of pathogenesis and host defense.

Authors:  Tobias M Hohl; Marta Feldmesser
Journal:  Eukaryot Cell       Date:  2007-09-21

Review 3.  Aspergillus vaccines: Hardly worth studying or worthy of hard study?

Authors:  Stuart M Levitz
Journal:  Med Mycol       Date:  2016-09-17       Impact factor: 4.076

Review 4.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Eosinophils are recruited in response to chitin exposure and enhance Th2-mediated immune pathology in Aspergillus fumigatus infection.

Authors:  Evan M O'Dea; Nansalmaa Amarsaikhan; Hongtao Li; Joshua Downey; Emery Steele; Steven J Van Dyken; Richard M Locksley; Steven P Templeton
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

6.  An inhalation model of airway allergic response to inhalation of environmental Aspergillus fumigatus conidia in sensitized BALB/c mice.

Authors:  Scott A Hoselton; Amali E Samarasinghe; Jena M Seydel; Jane M Schuh
Journal:  Med Mycol       Date:  2010-05-20       Impact factor: 4.076

7.  Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis.

Authors:  Stacy J Park; Molly A Hughes; Marie Burdick; Robert M Strieter; Borna Mehrad
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Charles A Specht; Stuart M Levitz
Journal:  MBio       Date:  2010-07-20       Impact factor: 7.867

9.  Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.

Authors:  F Zhu; G Ramadan; B Davies; D A Margolis; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

Review 10.  Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature.

Authors:  Melisa M Shah; Eric I Hsiao; Carl M Kirsch; Amit Gohil; Supriya Narasimhan; David A Stevens
Journal:  Diagn Microbiol Infect Dis       Date:  2018-02-02       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.